US-based medical device firm Boston Scientific has launched Axios stent and electrocautery enhanced delivery systems to manage two severe complications from pancreatitis via a minimally invasive endoscopic approach.

The Axios system will assist physicians in endoscopic management of pancreatic pseudocysts and several types of walled-off pancreatic necrosis.

The conditions interpret two types of pancreatic fluid collections (PFCs), which take place in 5% to 16% of patients with acute pancreatitis, and 20% to 40% of patients with chronic pancreatitis.

“The Axios stent and electrocautery enhanced delivery system provide a simpler and faster treatment option for patients.”

Physicians can use the Axios electrocautery-enhanced catheter to gain access to the PFC, under endoscopic ultrasound (EUS) guidance.

The Axios stent will be deployed to facilitate drainage of the PFC by creating a temporary channel between the PFC and the gastrointestinal tract.

It is reported that the large flanges on each end of the lumen-apposing stent decrease the risk of leakage and migration.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The MRI compatible, fully covered and self-expanding stent is claimed to be the only removable metal stent in the US indicated for PFC drainage.

Axios system inventor Kenneth Binmoeller said: "The Axios stent and electrocautery enhanced delivery system provide a simpler and faster treatment option for patients.

"We can now provide an endoscopic solution that provides immediate relief for these patients using one device in a single setting."

Earlier this month, the company secured FDA approval for its Blazer open-irrigated (OI) radiofrequency ablation catheter to treat Type I atrial flutter, an abnormal rhythm of the upper chambers of the heart.

Image: The Axios system combines a cautery-enabled access catheter with the Axios stent. Photo: courtesy of Boston Scientific Corporation.